Peak6 Investments LLC Intellia Therapeutics, Inc. Put Options Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$20.02 - $27.22 $600,600 - $816,600	30,000 Added 133.33%	52,500 $1.17 Million
Q1 2024 May 14, 2024	SELL	$23.82 - $32.8 $35,730 - $49,199	-1,500 Reduced 6.25%	22,500 $618,000
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $555,840 - $776,160	24,000 New	24,000 $731,000
Q1 2022 May 13, 2022	BUY	$58.27 - $118.99 $734,202 - $1.5 Million	12,600 Added 131.25%	22,200 $1.61 Million
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $967,296 - $1.33 Million	9,600 New	9,600 $1.14 Million

326

88.8M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.6B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.